Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Gastrointestinal 2 Thoracic 1 Lymphoid 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 193 pembrolizumab 156 Pemetrexed 136 Cisplatin 118 durvalumab 73 Paclitaxel 71 osimertinib 68 Nivolumab 66 Docetaxel 63 Specimen Handling 62 atezolizumab 58 Magnetic Resonance Spectroscopy 51 Etoposide 46 Gemcitabine 43 Radiotherapy 39 Radiosurgery 37 130-nm albumin-bound paclitaxel 34 Drug Therapy 30 Cetuximab 28 Bevacizumab 27 Ipilimumab 25 Taxes 23 cemiplimab 22 tislelizumab 20 Platinum 20 amivantamab 18 Radiation 18 Immunoglobulin G 17 Biopsy 17 1,2-diaminocyclohexaneplatinum II citrate 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

High-Intensity Interval Training × Thoracic × 90 days × Clear all

NCT06026111 2026-04-14

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡